Title: The%20Role%20of%20Phytoestrogens%20in%20Cancer%20Etiology
1The Role of Phytoestrogens in Cancer Etiology
- Susan E. McCann, PhD, RD
- Department of Epidemiology
- Division of Cancer Prevention and Population
Sciences - Roswell Park Cancer Institute
- susan.mccann_at_roswellpark.org
2What are phytoestrogens?
phytoestrogen
(plural phytoestrogens)
noun Plant sterol any one of a group of
sterols found in plants that can have an effect
on the body like that of a hormone. Soybeans and
their products contain phytoestrogens.
3Sources of Exogenous Estrogen Exposure
Dietary Estrogens
Synthetic Contaminants
Naturally Occurring
Growth Promoters
Xeno estrogens
Lignans
Others
Isoflavonoids
(diethy lstilboestrol)
Coumestans
Isoflavones
(DDT, PCB)
4Classification of phytoestrogens
- Isoflavones
- Genistein (plant precursor biochanin A)
- Daidzein (plant precursor formononetin)
- Lignans
- Enterolactone (plant precursor matairesinol)
- Enterodiol (plant precursor secoisolariciresinol
) - Coumestans
5Food Sources-Isoflavones
- Soybeans
- Soy meal
- Soy grits
- Soy flour
- Tofu, fermented soy products (miso, etc)
- Soy milk
- Lentils
- Dried beans (haricot, broad, kidney, lima)
- Chickpeas
- Processed foods (lunch meats, meal replacement
beverages, donuts)
6(No Transcript)
7Food Sources-Lignans
- Flaxseed
- Whole grain cereals (wheat, wheat germ, barley,
hops, rye, rice, brans, oats) - Fruits, vegetables, seeds (cherries, apples,
pears, stone fruits, sunflower seeds, carrots,
fennel, onion, garlic) - Beer from hops, bourbon from corn
8Top ten contributors to lignan intake, Western
New York Health Study (1996-2001)
9Food Sources-Coumestans
- Alfalfa sprouts
- Soybean sprouts
10Mean urinary excretion of phytoestrogens among
different populations
18000
16000
14000
12000
10000
8000
6000
4000
2000
0
Daidzein
Japanese Women
Finnish Omnivores
Finnish Vegetarians
Enterolactone
Oriental Immigrants
American Omnivores
Finnish Breast Cancer
American Vegetarians
American Macrobiotics
Enterodiol
Adapted from Adlercreutz Baillieres Clinical
Endocrinology and Metabolism 199812(4)605-623
11Chemical Structure Estradiol
Chemical Structure Estradiol
12Chemical structure Isoflavones
Genistein
Daidzein
13Chemical Structure-Lignans
Enterolactone
Matairesinol
Secoisolariciresinol
Enterodiol
14Chemical Structure Coumestans
Coumestrol
15Potential mechanisms of action
- Competitive inhibition of endogenous estrogen
- Stimulation of sex hormone binding globulin
synthesis - Inhibition of angiogenesis and cell cycle
progression - Additional anticarcinogenic effects
- Aromatase enzyme inhibition
- Antioxidant properties
16Potential mechanisms of action
- At high concentrations, genistein inhibits
proliferation of ER-positive MCF-7 breast cancer
cell lines - At low concentrations, however, genistein
stimulates proliferation. Also competes with
estradiol for ER binding and stimulates
expression of pS2 mRNA - Similar stimulatory effects have been reported
for daidzein, equol, and enterolactone
17Animal studies
- Reproductive disturbances in livestock grazing on
clover - Isoflavone-stimulated uterine hypertrophy in lab
animals - Decreased breast tumor proliferation in soy-fed
animals
18Epidemiologic evidence
- Ecologic
- Populations with high soy food intake tend to
have lower rates of breast, prostate, and colon
cancer - Migrant populations (presumably adapting western
diet) tend to develop cancer rates of adopted
country - Specific population subgroups, e.g., vegetarians
tend to have higher phytoestrogen intakes and
lower cancer rates
19Analytic studies Phytoestrogens and hormone
sensitive cancers
Cancer
Phytoestrogen
OR (95 CI)
Study design
Study
Urinary genistein Urinary enterlactone
Den Tonkelaar
Breast
0.83 (0.46-1.51) 1.43 (0.79-2.59)
Prospective
Urinary enterlactone
Pietinen
Breast
0.38 (0.18-0.77)
Prospective
Breast
0.27 (0.10-0.69) 0.36 (0.15-0.86)
Urinary equol Urinary enterlactone
Case-control
Ingram
Horn-Ross
Case-control
Breast
FFQ isoflavones FFQ lignans
0.92 (0.72-1.2) 1.1 (0.89-1.5)
FFQ daidzein FFQ coumestrol
0.57 (0.31-1.05) 0.48 (0.25-0.94)
Prostate
Case-control
Strom
20Odds ratios and 95 confidence intervals for risk
of breast cancer associated with dietary lignan
intake, Western New York Diet Study
Odds ratio (95 confidence interval)
Controls (n)
Cases (n)
Lignans, mcg/d
Premenopausal
1.00
103
136
Low (60-460)
Medium (460-670)
0.70 (0.47-1.03)
109
98
0.49 (0.32-0.75)
104
67
High (670-2480)
Postmenopausal
1.00
164
173
Low (60-460)
Medium (460-670)
0.75 (0.55-1.04)
167
139
High (670-2480)
0.72 (0.51-1.02)
163
127
21Odds ratios and 95 confidence intervals for risk
of ovarian cancer associated with dietary lignan
intake, WNYDS
Lignans, mcg/d
Odds ratio (95 confidence interval)
Cases (n)
Controls (n)
1.00
139
31
lt 304
0.59 (0.32-1.11)
139
21
304-408
0.81 (0.46-1.46)
140
30
408-536
0.74 (0.41-1.37)
139
26
536-708
0.43 (0.21-0.85)
139
16
gt 708
22Odds ratios and 95 confidence intervals for risk
of breast cancer associated with dietary lignan
intake by CYP17 genotype, WNYDS
Lignans, mcg/d
Odds ratio (95 confidence interval)
Controls (n)
Cases (n)
Premenopausal
A1A2 and A2A2
1.00
14
23
Low (130-500)
0.50 (0.14-1.80)
9
10
Medium (500-690)
0.12 (0.03-0.50)
15
5
High (690-2110)
A1A1
0.67 (0.25-1.81)
19
23
Low (130-500)
Medium (500-690)
0.59 (0.20-1.73)
15
17
0.71 (0.24-2.08)
14
18
High (690-2110)
23Odds ratios and 95 confidence intervals for risk
of breast cancer associated with dietary lignan
intake by CYP17 genotype, WNYDS
Lignans, mcg/d
Odds ratio (95 confidence interval)
Controls (n)
Cases (n)
Postmenopausal
A1A2 and A2A2
1.00
15
22
Low (130-500)
0.58 (0.23-1.48)
23
20
Medium (500-690)
0.61 (0.22-1.69)
17
17
High (690-2110)
A1A1
1.05 (0.39-2.87)
14
19
Low (130-500)
0.59 (0.21-1.67)
15
14
Medium (500-690)
18
19
High (690-2110)
0.62 (0.23-1.71)
24Future directions
- Much of the epidemiologic literature is
supportive of a beneficial effect of
phytoestrogens in cancer prevention - Biologic mechanisms need to be better elucidated
- Methods of phytoestrogen quantification need to
be improved - Genetic susceptibility may play an important role